Author | Susan N. Chi, MD | OncLive

Author | Susan N. Chi, MD

Articles

Dr. Chi on Response to Tazemetostat in Children With INI1-Negative Tumors

November 28, 2018

Video

Susan N. Chi, MD, senior physician, director, Pediatric Brain Tumor Clinical Trials Program, Dana-Farber Cancer Institute, assistant professor of pediatrics, Harvard Medical School, discusses response to tazemetostat in children with INI1-negative tumors.

Dr. Chi on Tazemetostat in Pediatric Patients With INI1-Negative Tumors

November 17, 2018

Video

Susan N. Chi, MD, senior physician, director, Pediatric Brain Tumor Clinical Trials Program, Dana-Farber Cancer Institute, assistant professor of pediatrics, Harvard Medical School, discusses the EZH2 inhibitor tazemetostat in pediatric patients with INI1-negative tumors.

Dr. Chi Discusses Tazemetostat Trial in INI1-Negative Pediatric Tumors

August 09, 2018

Video

Susan N. Chi, MD, senior physician, director, Pediatric Brain Tumor Clinical Trials Program, Dana-Farber Cancer Institute, assistant professor of pediatrics, Harvard Medical School, discusses a trial of tazemetostat in pediatric patients with INI1-negative tumors.

Dr. Chi Discusses Pediatric Atypical Teratoid Rhabdoid Tumors

July 23, 2018

Video

Susan N. Chi, MD, senior physician, director, Pediatric Brain Tumor Clinical Trials Program, Dana-Farber Cancer Institute, assistant professor of pediatrics, Harvard Medical School, discusses pediatric atypical teratoid rhabdoid tumors.

x